NRx Expands Ketamine Access for Suicidal Depression via FDA Program

NRx Expands Ketamine Access for Suicidal Depression via FDA Program

Imagine a world where hope reaches those in deepest despair. NRx Pharmaceuticals is making strides with an investigational ketamine therapy for suicidal depression, now more accessible through…